Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 283

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Open access
Taube, Janis M, Akturk, Guray, Angelo, Michael, Engle, Elizabeth L, Gnjatic, Sacha, Greenbaum, Shirley, Greenwald, Noah F, Hedvat, Cyrus V, Hollmann, Travis J, Juco, Jonathan, Parra, Edwin R, Rebelatto, Marlon C, Rimm, David L, Rodriguez-Canales, Jaime, Schalper, Kurt A, Stack, Edward C, Ferreira, Cláudia S, Korski, Konstanty, Lako, Ana, Rodig, Scott J, Schenck, Emanuel, Steele, Keith E, Surace, Michael J, Tetzlaff, Michael T, von Loga, Katharina, Wistuba, Ignacio I, Bifulco, Carlo B·2020·Journal for ImmunoTherapy of Cancer

Abstract

Objectives: The interaction between the immune system and tumor cells is an important feature for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) analyses are emerging technologies that can be used to help quantify immune cell subsets, their functional state, and their spatial arrangement within the tumor microenvironment. Methods: The Society for Immunotherapy of Cancer (SITC) convened a task force of pathologists and laboratory leaders from academic centers as well as experts from pharmaceutical and diagnostic companies to develop best practice guidelines for the optimization and validation of mIHC/mIF assays across platforms. Results: Representative outputs and the advantages and disadvantages of mIHC/mIF approaches, such as multiplexed chromogenic IHC, multiplexed immunohistochemical consecutive staining on single slide, mIF (including multispectral approaches), tissue-based mass spectrometry, and digital spatial profiling are discussed. Conclusions: mIHC/mIF technologies are becoming standard tools for biomarker studies and are likely to enter routine clinical practice in the near future. Careful assay optimization and validation will help ensure outputs are robust and comparable across laboratories as well as potentially across mIHC/mIF platforms. Quantitative image analysis of mIHC/mIF output and data management considerations will be addressed in a complementary manuscript from this task force.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jitc-2019-000155

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Research works printed but not linked: 6

  1. 10.1369/jhc.6P6945.2006 · doi:10.1369/jhc.6p6945.2006
  2. Gustavson, 2013, Tissue microarrays: leaping the gap between research and clinical adoption, Per Med, 10, 441, 10.2217/pme.13.42 · doi:10.2217/pme.13.42
  3. 10.1043/1543-2165-133.5.743 · doi:10.1043/1543-2165-133.5.743
  4. Dillon, 1998, The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin, Am J Pathol, 152, 75
  5. Surace M , DaCosta K , Huntley A , et al . Automated multiplex immunofluorescence panel for Immuno-oncology studies on formalin-fixed carcinoma tissue specimens. J Vis Exp 2019. doi:doi:10.3791/58390. [Epub ahead of print: 21 Jan 2019]. · doi:10.3791/58390
  6. 10.1158/1538-7445.SABCS18-LB-318 · doi:10.1158/1538-7445.sabcs18-lb-318

Cited by

See all 283

Metadata

Authors
Taube, J. M., Akturk, G., Angelo, M., Engle, E. L., Gnjatic, S., Greenbaum, S., Greenwald, N. F., Hedvat, C. V., Hollmann, T. J., Juco, J., Parra, E. R., Rebelatto, M. C., Rimm, D. L., Rodriguez-Canales, J., Schalper, K. A., Stack, E. C., Ferreira, C. S., Korski, K., Lako, A., Rodig, S. J., Schenck, E., Steele, K. E., Surace, M. J., Tetzlaff, M. T., von Loga, K., Wistuba, I. I., & Bifulco, C. B.
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2020-05
Volume
8
Issue
1
Pages
e000155
ISSN
2051-1426 (ISSN-L)
OpenAlex
W3024300243
Cited by
283
References
63
FWCI
11.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation. https://app.cochat.ai/papers/10.1136/jitc-2019-000155
The paper
Taube, J. M., Akturk, G., Angelo, M., Engle, E. L., Gnjatic, S., Greenbaum, S., Greenwald, N. F., Hedvat, C. V., Hollmann, T. J., Juco, J., Parra, E. R., Rebelatto, M. C., Rimm, D. L., Rodriguez-Canales, J., Schalper, K. A., Stack, E. C., Ferreira, C. S., Korski, K., Lako, A., . . . Bifulco, C. B. (2020). The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2019-000155

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.